Managing Incidental Findings in Human Subjects Research

管理人类受试者研究中的偶然发现

基本信息

  • 批准号:
    7126441
  • 负责人:
  • 金额:
    $ 28.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-26 至 2007-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This 2-year project tackles a profoundly important but widely ignored problem: how should researchers handle incidental findings that have potential clinical significance, what should consent forms say about this, and how should IRBs consider the potential for incidental findings in their review of protocols. By "incidental findings" we do not mean results on those variables of key interest in the research, but unexpected findings beyond the domain of focal research interest, such as a suspicious mass revealed in a functional MRI (fMRI) study, or an incidental finding of nonpaternity in genetic research on families. We will anchor our analysis by focusing on incidental findings in 4 research areas: (1) fMRI research, (2) CT colonography research, (3) genetic research on families, and (4) genomic microarray research. This project will have a normative and an empirical component. The normative work will focus on developing a consensus paper on how incidental findings should be managed by investigators and IRBs and model consent form language. This will be informed by collection and analysis of model consent forms and consent forms used by U.S. researchers in the 4 areas of study as posted on university, professional society, and governmental websites and on the World Wide Web. This project will be led by researchers in the University of Minnesota's Consortium on Law and Values in Health, Environment & the Life Sciences, collaborating with a senior empiricist expert in content analysis and a Working Group of prominent national scholars. Project outcomes will include: publication of the consensus recommendations and model consent form language, a conference presenting our conclusions plus papers on incidental findings management in the 4 targeted research areas and analysis of the legal implications of incidental findings, a published symposium in a prominent journal collecting these papers, and a website offering tools such as model consent form language and an annotated bibliography with web links.
描述(由申请人提供):这个为期2年的项目解决了一个非常重要但被广泛忽视的问题:研究人员应该如何处理具有潜在临床意义的偶然发现,同意书应该对此说些什么,以及irb在审查方案时应该如何考虑偶然发现的可能性。我们所说的“偶然发现”并不是指研究中那些关键感兴趣的变量的结果,而是指超出重点研究兴趣领域的意外发现,如功能性磁共振成像(fMRI)研究中发现的可疑肿块,或在家庭遗传研究中偶然发现的非父系关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN M. WOLF其他文献

SUSAN M. WOLF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN M. WOLF', 18)}}的其他基金

Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight
纳米诊断和纳米治疗:建立研究道德和监督
  • 批准号:
    7818595
  • 财政年份:
    2009
  • 资助金额:
    $ 28.69万
  • 项目类别:
Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight
纳米诊断和纳米治疗:建立研究道德和监督
  • 批准号:
    7944119
  • 财政年份:
    2009
  • 资助金额:
    $ 28.69万
  • 项目类别:
Managing Incidental Findings in Human Subjects Research
管理人类受试者研究中的偶然发现
  • 批准号:
    6965929
  • 财政年份:
    2005
  • 资助金额:
    $ 28.69万
  • 项目类别:
Managing Incidental Findings and Research Results in Genomic Biobanks and Archive
管理基因组生物库和档案中的偶然发现和研究结果
  • 批准号:
    7938783
  • 财政年份:
    2005
  • 资助金额:
    $ 28.69万
  • 项目类别:
Managing Incidental Findings and Research Results in Genomic Biobanks and Archive
管理基因组生物库和档案中的偶然发现和研究结果
  • 批准号:
    7736705
  • 财政年份:
    2005
  • 资助金额:
    $ 28.69万
  • 项目类别:

相似海外基金

Contract HHSN261201200035I, Cancer Prevention Agent Development Program: Early Phase Clinical Research, 9/24/2012 - 9/23/2017Task Order HHSN26100005, Phase I Trial of Berberine in Subjects with U
合同 HHSN261201200035I,癌症预防剂开发计划:早期临床研究,2012 年 9 月 24 日 - 2012 年 9 月 23 日任务订单 HHSN26100005,小檗碱在 U 受试者中的 I 期试验
  • 批准号:
    8948660
  • 财政年份:
    2014
  • 资助金额:
    $ 28.69万
  • 项目类别:
No More Hand Me Downs: A National Broadcast Film on Clinical Research with Childr
不再有旧事:一部关于儿童临床研究的全国广播电影
  • 批准号:
    8521681
  • 财政年份:
    2013
  • 资助金额:
    $ 28.69万
  • 项目类别:
CC: Clinical Research
CC:临床研究
  • 批准号:
    8719569
  • 财政年份:
    2013
  • 资助金额:
    $ 28.69万
  • 项目类别:
Emory Clinical Research Site for NEXT
埃默里大学 NEXT 临床研究中心
  • 批准号:
    8709004
  • 财政年份:
    2011
  • 资助金额:
    $ 28.69万
  • 项目类别:
Emory Clinical Research Site for NEXT
埃默里大学 NEXT 临床研究中心
  • 批准号:
    8339420
  • 财政年份:
    2011
  • 资助金额:
    $ 28.69万
  • 项目类别:
Emory Clinical Research Site for NEXT
埃默里大学 NEXT 临床研究中心
  • 批准号:
    8865705
  • 财政年份:
    2011
  • 资助金额:
    $ 28.69万
  • 项目类别:
Emory Clinical Research Site for NEXT
埃默里大学 NEXT 临床研究中心
  • 批准号:
    8526589
  • 财政年份:
    2011
  • 资助金额:
    $ 28.69万
  • 项目类别:
Emory Clinical Research Site for NEXT
埃默里大学 NEXT 临床研究中心
  • 批准号:
    8242141
  • 财政年份:
    2011
  • 资助金额:
    $ 28.69万
  • 项目类别:
CLINICAL RESEARCH OFFICE (SHARED RESOURCE)
临床研究办公室(共享资源)
  • 批准号:
    7944562
  • 财政年份:
    2009
  • 资助金额:
    $ 28.69万
  • 项目类别:
CC: Clinical Research
CC:临床研究
  • 批准号:
    7510973
  • 财政年份:
    2008
  • 资助金额:
    $ 28.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了